GC044 Electrolyte And Acid-base Disorders
Electrolyte and acid-base disorders are clinical conditions involving abnormal concentrations of key ions (sodium, potassium, calcium, magnesium, phosphate) or disturbances in blood pH homeostasis (acidosis or alkalosis), arising from metabolic or respiratory causes and affecting cellular and organ function.
Electrolyte and Acid-Base Disorders
This lecture, delivered by Dr. Desmond Yap (Division of Nephrology, HKU), is a foundational pillar of nephrology, critical care, and general internal medicine. It covers the four major categories of electrolyte and acid-base disturbances you will encounter daily as a clinician: metabolic acidosis, metabolic alkalosis, respiratory acidosis/alkalosis, hypo/hypernatraemia, and hypo/hyperkalaemia [1]. These topics are among the most frequently examined in the Fourth Summative—tested via MCQs (EMQs with electrolyte/acid-base options), SAQs (ABG interpretation, management of DKA/lactic acidosis), and minicases (confused patient with abnormal biochemistry).
Learning Objectives [1]:
- Understand the mechanism behind different acid-base and electrolyte disturbances.
- Develop a systematic approach to investigate and diagnose these disorders.
- Appreciate the general management principles for correction.
The lecture fits into the broader curriculum alongside: GC 078 (DKA), GC 039 (hypercalcaemia/hypocalcaemia), Renal Tubular Disorders (Prof Chan), Chemical Pathology seminars (Na and K), and CFB 22 (fluids and electrolytes).
Core Concepts and Mechanisms (from First Principles)
Every enzyme in the human body functions optimally at a narrow pH range. The body maintains arterial pH at 7.35–7.45 (corresponding to [H⁺] of ~35–45 nmol/L). When pH deviates beyond this range, protein structures denature, enzyme kinetics fail, and cellular functions collapse.
Normal pH: 7.4 (range 7.35–7.45); pH 7.4 = [H⁺] 40 nmol/L. Lethal: pH < 7.1 or > 7.7 [1]
This equation tells us pH is determined by the ratio of HCO₃⁻ (metabolic component, controlled by kidneys) to pCO₂ (respiratory component, controlled by lungs). If HCO₃⁻ drops or pCO₂ rises, pH falls (acidosis). If HCO₃⁻ rises or pCO₂ drops, pH rises (alkalosis) [2][3].
Mnemonic: Acidity = Bicarb / Carbon Dioxide (A = B/CD) [3].
Acidosis = a process leading to increase in plasma [H⁺]. Alkalosis = a process leading to removal of plasma [H⁺]. Acidaemia = [H⁺] > normal. Alkalaemia = [H⁺] < normal. [1]
Key Distinction
Acidosis ≠ acidaemia. You can have an acidosis process running (e.g., chronic metabolic acidosis from CKD) but if the lungs compensate well, the pH remains normal—there is acidosis without acidaemia. This distinction is commonly tested.
The body never overcompensates—compensation brings pH toward normal but does not fully correct it (with one exception: chronic respiratory alkalosis may fully compensate).
Lungs compensate immediately; Kidneys take several days. [1]
| Primary Disorder | Primary Change | Compensation | Mechanism |
|---|---|---|---|
| Metabolic acidosis (↓HCO₃⁻) | ↓pH | Stimulate resp centre → ↓pCO₂ (compensatory resp alkalosis) | Chemoreceptors detect ↑[H⁺], drive hyperventilation (Kussmaul breathing) |
| Metabolic alkalosis (↑HCO₃⁻) | ↑pH | Suppress resp centre → ↑pCO₂ (compensatory resp acidosis) | ↓[H⁺] reduces respiratory drive → hypoventilation |
| Respiratory acidosis (↑pCO₂) | ↓pH | Kidney conserves HCO₃⁻ → ↑HCO₃⁻ (compensatory met alkalosis) | Proximal tubule ↑HCO₃⁻ reabsorption; collecting duct ↑H⁺ excretion |
| Respiratory alkalosis (↓pCO₂) | ↑pH | Kidney excretes HCO₃⁻ → ↓HCO₃⁻ (compensatory met acidosis) | ↓HCO₃⁻ reabsorption in proximal tubule |
Expected Compensation Formulas (from senior notes, useful for data interpretation) [4]:
| Disorder | Expected Compensation |
|---|---|
| Metabolic acidosis | Winter's formula: pCO₂ = 1.5 × [HCO₃⁻] + 8 ± 2 |
| Metabolic alkalosis | pCO₂ rises ~0.6 mmHg per 1 mmol/L ↑HCO₃⁻ |
| Acute respiratory acidosis | HCO₃⁻ rises ~1 per 10 mmHg ↑pCO₂ |
| Chronic respiratory acidosis | HCO₃⁻ rises ~3.5 per 10 mmHg ↑pCO₂ |
| Acute respiratory alkalosis | HCO₃⁻ drops ~2 per 10 mmHg ↓pCO₂ |
| Chronic respiratory alkalosis | HCO₃⁻ drops ~4–5 per 10 mmHg ↓pCO₂ |
If compensation is outside expected ranges → mixed acid-base disorder.
Part 1: Metabolic Acidosis
Characterized by ↓HCO₃⁻ (Normal: 22–28 mmol/L; < 22 = metabolic acidosis). Compensated with hyperventilation → reduced pCO₂. [1]
Steps: (1) Confirm it is metabolic acidosis. (2) Determine the Anion Gap. (3) If normal AG → determine urine AG. (4) Look for any osmolar gap. (5) Check for mixed disorders (ΔAG vs ΔHCO₃⁻). [1]
(The lecturer explicitly notes steps 3 and 5 are "advanced/too advanced for MBBS" but step 2—the anion gap—is absolutely core.)
Why does it exist? Plasma must be electrically neutral—total cations = total anions. We routinely measure Na⁺, Cl⁻, and HCO₃⁻, but there are unmeasured anions (albumin, phosphate, sulphate, organic acids) that make up the "gap."
AG = Na⁺ − Cl⁻ − HCO₃⁻. Example: 140 − 105 − 25 = 10. Normal AG ≈ 8–14 [1]
Why the AG matters in metabolic acidosis:
When an acid (HA) is added to blood, it dissociates into H⁺ + A⁻. The H⁺ consumes HCO₃⁻ (buffering), so HCO₃⁻ drops. Meanwhile, A⁻ (the conjugate base anion) accumulates. If A⁻ is a "measured" anion like Cl⁻, Cl⁻ replaces HCO₃⁻ and the AG stays normal. If A⁻ is "unmeasured" (like lactate, ketoacids), the AG rises because HCO₃⁻ drops without a compensatory Cl⁻ rise.
In normal AG acidosis, ↓HCO₃⁻ is compensated by ↑Cl⁻ (hyperchloraemic acidosis). In high AG acidosis, ↓HCO₃⁻ is due to accumulation of unmeasured anions. [1]
Causes of ↑AG: [1]
- DKA, alcoholic ketoacidosis
- Lactic acidosis
- Ingestion: salicylate, formic acid (methanol), glycolate (ethylene glycol)
- Renal failure: sulphate, phosphate, hippurate
- Rhabdomyolysis: release of organic acids
- Remarks: altered AG in paraproteinaemia (e.g., ↓ in IgG gammopathy; ↑ in IgA gammopathy)
Classic Mnemonic: MUDPILES
Methanol, Uraemia, DKA, Propylene glycol/Paracetamol, Isoniazid/Iron, Lactic acidosis, Ethylene glycol, Salicylates. While not on the lecture slides, examiners often expect you to think of these causes systematically.
Paraproteinaemia and AG: IgG carries a net negative charge (raises AG); IgA carries a net positive charge (lowers AG). This is a subtle point the lecturer specifically includes—it can confound AG interpretation in myeloma patients [1].
Characterised by ↑Cl⁻. Causes: [1]
- GI loss of HCO₃⁻: diarrhoea
- Renal loss of HCO₃⁻: proximal RTA (type II), carbonic anhydrase inhibitors
- Failure to excrete H⁺: distal RTA (type I), type IV RTA
- Ingestion of excessive Cl⁻: NH₄Cl
- Increased reabsorption of Cl⁻: ureterosigmoidostomy
Why ureterosigmoidostomy? The sigmoid colon actively absorbs Cl⁻ and secretes HCO₃⁻. When urine drains into it, the colon exchanges Cl⁻ for HCO₃⁻ → patient loses HCO₃⁻ and gains Cl⁻ → hyperchloraemic metabolic acidosis.
Calculated osmolality = 2×[Na⁺] + urea + glucose. Osmolar gap = Measured osmolality − Calculated osmolality. ↑Osmolar gap = presence of an unmeasured osmotically active substance (e.g., ingestion of alcohol-related compounds). [1]
This is clinically vital when you suspect toxic alcohol ingestion (methanol, ethylene glycol). A patient with HAGMA + ↑osmolar gap → think toxic alcohol ingestion as the primary diagnosis.
Lactate is produced when pyruvate is reduced under anaerobic conditions (glycolysis without oxidative phosphorylation). Normal lactate < 2 mmol/L.
Type A (O₂ deficiency—overproduction): [1]
- Circulatory: hypotension
- Respiratory: hypoxia
- Haemoglobin: CO poisoning
- Increased metabolic demand: grand mal seizure, severe exercise
Type B (without hypoxaemia—reduced metabolism): [1]
- Liver disease
- Alcoholism
- Thiamine deficiency
- Phenformin, metformin
Rate of production up to 72 mmol/min with total hypoxia. Diagnosis: High AG metabolic acidosis + measure plasma lactate (normal < 2 mmol/L). [1]
Treatment of Type A L-lactic acidosis: Most effective = improve O₂ delivery to tissue (correct hypotension, hypoxaemia). NaHCO₃ therapy ineffective unless lactate production is controlled—its use may buy time. Na⁺ load limits massive use. Haemodialysis with bicarbonate dialysis is an option. [1]
Past Paper Alert (2021 MCQ Q55)
A 68-year-old chronic drinker with DM on metformin and insulin, presents with hypotension (BP 84/44), tachycardia, AKI (Cr 367), low HCO₃⁻ (11), and random glucose 15. The MOST LIKELY cause of the acid-base disturbance is L-lactic acidosis (Type A) — the key discriminator is the hypotension/shock picture. DKA is less likely because glucose is only 15 (not markedly elevated) and there's no mention of ketonaemia. Alcoholic ketoacidosis is possible but the shock picture with AKI points to lactic acidosis as the primary driver. Type IV RTA would not cause such severe acidosis. Also note: metformin in renal failure can contribute to Type B lactic acidosis, but the shock component makes Type A dominant. [5]
Determine cause and treat the underlying cause. Some causes have independent threat to life (e.g., methanol poisoning). There may be specific treatment (e.g., fomepizole/ethanol for methanol poisoning). Correction of HCO₃⁻ by NaHCO₃. [1]
This is a favourite exam topic because it tests understanding of physiology:
1. Induces hypokalaemia — NaHCO₃ raises pH → alkalosis shifts K⁺ into cells. Dangerous if patient already has low K⁺ (e.g., DKA where total body K⁺ is depleted but serum K⁺ appears normal due to acidotic shift out of cells) [1].
2. Decreases ionic calcium — raising pH increases the proportion of calcium bound to albumin → ↓free/ionized Ca²⁺. Problematic in CRF patients who already have hypocalcaemia [1].
3. Volume expansion from Na⁺ load — 1 mmol HCO₃⁻ carries 1 mmol Na⁺. If 200 mmol NaHCO₃ given, that's 200 mmol Na⁺ = more than 1 litre of normal saline (which has 154 mmol Na⁺) [1].
4. Too rapid correction → paradoxical cerebral acidosis [1].
When NaHCO₃ is given IV, it reacts with H⁺ to form CO₂ and H₂O in the plasma. CO₂ crosses the blood-brain barrier (BBB) freely, but HCO₃⁻ does NOT cross the BBB easily. In the CSF, CO₂ is converted back to H⁺ + HCO₃⁻ by carbonic anhydrase → CSF pH drops (becomes more acidotic) even as blood pH is being corrected. [1]
This is why rapid NaHCO₃ infusion can paradoxically worsen neurological status.
HCO₃⁻ deficit = [HCO₃⁻ deficit per litre] × HCO₃⁻ space (= BW × 0.6). Usually only half the amount is given (i.e., BW × 0.3). Only replace to a safe level acutely (pH ~7.1), then slow correction. Give half the dose initially, recheck afterwards. Beware fluid overload in oliguric patients. [1]
Part 2: Renal Tubular Acidosis (RTA)
This section is extremely high-yield because it integrates acid-base physiology with renal tubular function—frequently tested in MCQs, EMQs, and data interpretation.
RTA: Characterised by normal AG acidosis with: [1] 1. HypoK⁺: Proximal RTA (Type II), Distal RTA (Type I), Mixed (Type III) 2. HyperK⁺: Type IV RTA
Mechanism from first principles: The proximal convoluted tubule (PCT) normally reabsorbs ~85% of filtered HCO₃⁻. It does this via the Na⁺/H⁺ exchanger on the apical membrane: H⁺ is secreted into the lumen → combines with HCO₃⁻ → forms CO₂ + H₂O (via carbonic anhydrase IV on the brush border) → CO₂ diffuses into the cell → reformed into HCO₃⁻ + H⁺ (via intracellular carbonic anhydrase II) → HCO₃⁻ exits basolaterally.
In proximal RTA, the reabsorption threshold for HCO₃⁻ is lowered (normally ~25 mmol/L). So when plasma HCO₃⁻ is above this lowered threshold, massive HCO₃⁻ is lost in the urine. Once plasma HCO₃⁻ falls to the new (lower) threshold, reabsorption "catches up" and a new steady state is reached at a lower plasma HCO₃⁻.
Characterised by ↓HCO₃⁻ reabsorption threshold → loss of HCO₃⁻ in urine → low plasma HCO₃⁻ → normal AG metabolic acidosis with compensatory hyperchloraemia → alkaline urine (pH usually > 6). [1]
Loss of Na⁺ coupling with loss of HCO₃⁻ → hypovolaemia → secondary hyperaldosteronism → hypoK⁺. [1]
Associated with hyperphosphaturia, hypercitraturia (which prevents nephrocalcinosis/stones), hyperuricuria. Hyperphosphaturia → rickets, osteomalacia. [1]
Fanconi's syndrome = pan-dysfunction of proximal tubules with aminoaciduria, glycosuria on top of RTA and hyperphosphataemia. [1]
Why No Kidney Stones in Proximal RTA?
Proximal RTA has hypercitraturia (citrate is a stone inhibitor). In contrast, distal RTA has hypocitraturia → nephrocalcinosis and kidney stones. This is a common exam discriminator.
Mechanism from first principles: The α-intercalated cells of the collecting duct secrete H⁺ via the H⁺-ATPase pump on the apical membrane. This creates a steep H⁺ gradient (urine pH can go as low as 4.5). In distal RTA, either the pump is defective or H⁺ leaks back through a permeable membrane.
Due to inability to excrete H⁺: (a) H⁺-ATPase pump defect, or (b) H⁺ back-leak (increased permeability). Urine pH always > 6 because of failure to maintain a steep plasma-urine H⁺ gradient. [1]
↓H⁺ excretion → ↑K⁺ excretion for exchange of Na⁺ reabsorption in distal tubule → hypoK⁺. [1]
Why hypoK⁺ in distal RTA? Normally, both H⁺ and K⁺ can be secreted in exchange for Na⁺ reabsorption at the collecting duct. When H⁺ secretion fails, K⁺ secretion increases to compensate for Na⁺ reabsorption → renal K⁺ wasting → hypoK⁺.
Acidosis → ↑Ca²⁺ resorption from bone AND ↓tubular Ca²⁺ and PO₄ reabsorption → hypercalciuria → nephrocalcinosis/kidney stones. [1]
| Feature | Proximal RTA (Type II) | Distal RTA (Type I) |
|---|---|---|
| Basic defect | ↓HCO₃⁻ reabsorption threshold | Failure to excrete H⁺ |
| AG | Normal | Normal |
| Serum K⁺ | Low | Low |
| Urine pH | > 6 (when HCO₃⁻ above threshold) | Always > 6 |
| Nephrocalcinosis/stones | No (↑citraturia) | Yes (↓citraturia, ↑Ca²⁺ excretion) |
| Bone disease | Rickets/osteomalacia (PO₄ wasting) | Possible but less prominent |
| Fanconi syndrome | Yes (if pan-tubular) | No |
| HCO₃⁻ dose needed | Very high (lost in urine) | Lower |
Proximal RTA causes: Hereditary (cystinosis, galactosaemia, Wilson's disease, Lowe's syndrome); Acquired (dysparaproteinaemia, heavy metal poisoning, carbonic anhydrase inhibitors, amyloidosis, renal transplant rejection, Sjögren's). [1]
Distal RTA causes: Hereditary (primary hypercalciuria, Marfan's, Ehlers-Danlos); Acquired (autoimmune: Sjögren's, RA, SLE, PBC; Drugs: amphotericin B, lithium, analgesic nephropathy; Renal: CRF, obstruction, interstitial nephritis, medullary sponge disease; Paraproteinaemia; HyperPTH, hyperCa²⁺, hypervitamin D). [1]
Clinical suspicion: Normal AG acidosis + hypoK⁺ (Hint: ↑Cl⁻ with normal Na⁺) + Urine pH > 5.5 in the presence of acidaemia. [1]
Confirmatory tests: [1]
- FEHCO₃⁻ (Fractional Excretion of Bicarbonate): Proximal RTA > 15% (sensitivity increases after NaHCO₃ infusion). Distal RTA < 5%.
- NH₄Cl acid loading test: Normal urine pH < 5.5. Distal RTA: urine pH remains > 6.0. Proximal RTA: variable.
Characterised by normal AG metabolic acidosis + hyperK⁺. Mechanism: aldosterone deficiency/resistance. Aldosterone promotes distal K⁺ and H⁺ secretion and Na⁺ reabsorption. Deficiency → retention of K⁺ (hyperkalaemia) + decreased H⁺ excretion (acidosis, usually mild). Urine pH variable. [1]
Causes: Drugs (ACEI, ARB, K⁺-sparing diuretics: spironolactone, amiloride, triamterene; Cyclosporin A, Tacrolimus), Hyporeninism (diabetic nephropathy), Renal failure, Mineralocorticoid deficiency, Kidney transplant rejection (tubulitis). [1]
Exam Discriminator: RTA Type
The potassium level is the KEY discriminator: HypoK⁺ + normal AG acidosis = Type I or II RTA. HyperK⁺ + normal AG acidosis = Type IV RTA. This comes up in MCQs repeatedly—e.g., a diabetic on an ACEI with mild metabolic acidosis and high K⁺ → Type IV RTA [5].
Type I & II RTA: [1] 1. Correct acidosis with oral NaHCO₃ (very high dose required in proximal RTA because of urinary HCO₃⁻ loss). 2. Potassium citrate is a better alternative for distal RTA (citrate → converted to HCO₃⁻ by liver, also ↑urinary citrate to prevent stones). 3. K⁺ supplement for hypoK⁺. 4. Distal RTA due to Sjögren's: steroids.
Type IV RTA: [1] 1. Stop/reduce inciting drugs. 2. Loop diuretics + low K⁺ diet for hyperK⁺.
Causes: [1] Loss of H⁺:
- GI: vomiting, nasogastric drainage
- Renal: diuretics (thiazide, furosemide), hypoK⁺, mineralocorticoid excess (primary or secondary), Bartter's/Gitelman's syndrome
Retention of HCO₃⁻:
- Intake of NaHCO₃
- Milk-alkali syndrome
Treatment: [1]
- If ECF contracted → expand with saline (HCO₃⁻ will fall with volume expansion)
- Correct hypoK⁺
- If ECF expanded → correct alkalosis with IV HCl or oral NH₄Cl
Why does volume contraction maintain metabolic alkalosis? When ECF is contracted, the kidneys avidly reabsorb Na⁺. In the proximal tubule, Na⁺ reabsorption is coupled with HCO₃⁻ reabsorption → the kidneys cannot excrete excess HCO₃⁻. Expanding ECF with saline restores Na⁺ delivery → kidneys can now excrete excess HCO₃⁻ → alkalosis resolves. This is called "saline-responsive" metabolic alkalosis.
Why hypoK⁺ causes metabolic alkalosis: When K⁺ is low, cells release K⁺ and take up H⁺ to maintain electrical neutrality → intracellular acidosis → in the kidney, intracellular acidosis in tubular cells drives ↑H⁺ secretion and ↑HCO₃⁻ reabsorption → metabolic alkalosis [6].
Part 4: Sodium Disorders
[Na⁺] does not reflect absolute content of Na⁺ in body, but the amount of solvent—water. Na⁺ is primarily an extracellular cation. In the absence of Na⁺ loss or retention: hypoNa⁺ = water retention; hyperNa⁺ = water depletion. Complicated when there is also Na⁺ loss or retention. [1]
This is the single most important concept in sodium disorders: serum [Na⁺] is a marker of water balance, not sodium balance. Volume status (assessed clinically) tells you about total body sodium [3].
↓Serum [Na⁺] but normal osmolality. Due to occupation of large amount of non-water (e.g., fat, paraprotein) in plasma → ↑plasma volume (denominator) while actual plasma water Na⁺ (numerator) is normal → [Na⁺] appears low. Clue: check serum osmolality—normal. Confirmation: check plasma water [Na⁺]. Causes: hyperglycaemia, ↑↑TG, paraproteinaemia, ↑↑WCC. [1]
Hyperglycaemia and Sodium
Hyperglycaemia causes true dilutional hyponatraemia (not just laboratory artifact)—glucose is osmotically active, pulling water from ICF to ECF, diluting Na⁺. For every 5.5 mmol/L rise in glucose above normal, Na⁺ drops by ~2.4 mmol/L. This is NOT pseudohyponatraemia—it's redistribution. The slide lists hyperglycaemia under pseudohyponatraemia, but strictly speaking, the osmolality will be elevated (not normal). Examiners may test this distinction.
Steps: [1] 1. Serum osmolarity? (↓ = true hyponatraemia) 2. Volume status? 3. Urine osmolarity? ( > 100 = ADH is working; appropriate?) 4. Urine Na⁺ level? ( > 20 = inappropriate, i.e., SIADH)
| Volume Status | Urine Na⁺ < 20 | Urine Na⁺ > 20 |
|---|---|---|
| Hypovolaemic | Extrarenal loss (GI, 3rd space, burns) | Renal loss (diuretics, Addison's, salt-wasting nephropathy, cerebral salt wasting) |
| Euvolaemic | Primary polydipsia (dilute urine) | SIADH (concentrated urine, urine osm > 100) |
| Hypervolaemic | CHF, cirrhosis, nephrotic syndrome (effective hypovolaemia → RAAS activation → Na⁺ retention but dilutional) | Advanced renal failure |
CNS: meningitis, encephalitis, brain abscess, head trauma, SAH, CVA, raised ICP. Respiratory: CA lung, chest infection, positive pressure breathing. Drugs: SSRIs, ecstasy. Hypothyroidism. [1]
2025 MCQ Q12
A 45-year-old lady on Lexapro (SSRI) with generalised malaise → the answer is hyponatraemia (SIADH from SSRI). This is a classic exam stem [5].
Non-specific: malaise, lethargy, headache. Confusion, convulsion, coma. More serious with acute hyponatraemia. [1]
Acute ( < 48h): More serious symptoms, severe at [Na⁺] < 120, less complications if corrected rapidly. Chronic ( > 72h): Symptoms may not develop even at [Na⁺] < 110, more prone to CNS complications with rapid correction. [1]
Why the difference? In chronic hyponatraemia, brain cells adapt by extruding osmolytes (organic solutes like taurine, myoinositol) to match the low extracellular osmolality. If you rapidly correct the Na⁺, the extracellular osmolality rises faster than the brain can re-accumulate osmolytes → water rushes out of brain cells → oligodendrocyte damage → central pontine myelinolysis (osmotic demyelination syndrome).
Rate of correction: SLOW for chronic hyponatraemia ( > 2 days): < 0.5 mmol/L/hr, or < 12 mmol/L/day. Too rapid correction → central pontine myelinolysis. Treat according to ECF volume status. Hypertonic saline only in very experienced hands. Demeclocycline or V2 antagonist (tolvaptan) can be considered in SIADH. [1]
Volume depletion assessment: Mild (loss of skin turgor) = 5% BW loss. Moderate (postural hypotension) = 10%. Severe (shock) = 15%. Mild oedema = 5% excess. Replace volume with normal saline cautiously. Initial 1/3 in first 8 hours, reduce speed afterwards. Monitor [Na⁺] regularly. [1]
In pure water loss: Water deficit = TBW × ([Na⁺]/140 − 1). Rate: 1/3 rule (1/3 in first 8h, 1/3 in next 16h, 1/3 in third 24h). Replace ongoing losses. Max decrease 12 mmol/24h unless seriously symptomatic. Too rapid → cerebral oedema (rapidly reduced plasma osmolality → water influx into cells). [1]
Part 5: Potassium Disorders
K⁺ is an intracellular cation (ICF: 150 mmol/L; ECF/serum: 3.5–5.0 mmol/L). Na-K-ATPase pumps K⁺ into cells. Highly influenced by acid-base status: acidosis → K⁺ moves out of cells (and vice versa). Severe hypoK⁺ and hyperK⁺ are life-threatening → cardiac arrhythmia. [1]
TTKG = (Urine [K⁺] × Serum Osm) / (Serum [K⁺] × Urine Osm). In hypoK⁺: TTKG > 4 indicates renal K⁺ loss. In hyperK⁺: TTKG < 6 indicates inappropriate renal response (should be high if kidney is working properly). [1]
Why TTKG? Raw urine K⁺ concentration is misleading because urine is concentrated/diluted in the collecting duct. The TTKG corrects for this by estimating K⁺ concentration at the cortical collecting duct (before concentration changes).
Hypokalaemia
Muscle weakness, paralysis (proximal myopathy). Cardiac arrhythmia (particularly when [K⁺] < 2.0). ECG changes: large U wave, loss of T wave, prolonged QT interval. Ileus, constipation. Rhabdomyolysis. Polyuria (impaired concentrating ability of collecting duct). [1]
Why ECG changes in hypoK⁺? K⁺ determines the resting membrane potential of cardiomyocytes (Nernst equation). Low ECF K⁺ → more negative resting membrane potential → delayed repolarisation → prominent U waves and QT prolongation → predisposition to torsades de pointes and VF.
Oral replacement when mild. Use IV KCl when: oral not possible (e.g., vomiting), moderate to severe (K⁺ ≤ 2.5). Always dilute IV KCl in NS. Cannot calculate exact amount needed because K⁺ is largely intracellular with ICF/ECF discrepancy. Initial distribution in ECF only—40 mmol K⁺ will increase [K⁺] ~1.5 mmol/L. [1]
Never Give IV KCl Undiluted or as a Bolus!
Concentrated IV KCl bolus can cause fatal cardiac arrest. Always dilute in NS and infuse at controlled rates (usually max 10–20 mmol/hr via peripheral line, up to 40 mmol/hr via central line with cardiac monitoring).
Hyperkalaemia
Symptoms: muscle weakness, usually occurs when [K⁺] > 8. Cardiac arrhythmia: may occur with [K⁺] > 6.0. Rate of rise is important—chronic hyperK⁺ is more tolerable. ECG: peaked T waves, widening of QRS, loss of P waves → eventually sine wave → VF/asystole. [1]
ECG progression of hyperkalaemia:
| [K⁺] Level | ECG Finding |
|---|---|
| 5.5–6.5 | Peaked (tented) T waves |
| 6.5–7.5 | Prolonged PR interval, loss of P waves |
| 7.5–8.0 | Widened QRS |
| > 8.0 | Sine wave pattern → VF/asystole |
History, diet, drug history. Repeat [K⁺] if no apparent cause (pseudohyperK? haemolysis). P/E—volume depleted? RFT. TTKG < 6 indicates inappropriate renal response to hyperkalaemia. [1]
Pseudohyperkalaemia: caused by haemolysis during blood draw, prolonged tourniquet use, fist clenching, or very high WCC/platelet count (K⁺ leaks from cells in vitro). Always repeat if unexpected.
EMERGENCY (arrhythmia, ECG changes): [1] 1. IV Calcium gluconate — effect within minutes. Protects heart (raises threshold potential) but does NOT reduce [K⁺]. May repeat in 5 min if no effect. 2. NaHCO₃ infusion — shifts K⁺ into cells. Effect within 30 min, lasts several hours. 3. IV Insulin/Dextrose (10 units insulin + 30g glucose as 60 mL D50) — shifts K⁺ into cells. Effect within 1 hour, lasts 5–6 hours. 4. Urgent haemodialysis — most effective at removing K⁺, but takes time to set up.
Non-emergency: [1]
- Cation-exchange resin (Na⁺/Ca²⁺ resin, e.g., calcium resonium) — oral or enema
- Loop diuretics if not oliguric
- Remove underlying cause (stop drugs, volume expansion for depletion)
- Correct metabolic acidosis
- Dialysis (HD or PD)
- Low K⁺ diet
Treatment Logic: Stabilize → Shift → Remove
The emergency management follows a logical sequence: (1) Stabilize the myocardium (IV calcium), (2) Shift K⁺ into cells temporarily (insulin/dextrose, NaHCO₃, salbutamol nebuliser), (3) Remove K⁺ from body permanently (dialysis, resins, diuretics). This framework is how examiners expect you to structure your answer.
Part 6: Integration with Related Lectures
DKA presents with high AG metabolic acidosis (ketoacids). Serum K⁺ may appear normal on admission due to acidotic shift, but total body K⁺ is depleted from osmotic diuresis. Giving insulin shifts K⁺ back into cells → risk of lethal hypokalaemia if not supplemented [7].
Relevant to distal RTA (hyperCa²⁺ damages the collecting duct → failure to acidify urine). Also connects to the 2025 MCQ Q13: chronic smoker with haemoptysis, bone pain, and lung mass → likely hypercalcaemia from PTHrP-secreting squamous cell lung cancer [5].
Both cause metabolic alkalosis + hypoK⁺. Bartter's mimics furosemide effect (thick ascending limb defect → hypokalaemia, metabolic alkalosis, hypercalciuria). Gitelman's mimics thiazide effect (distal tubule defect → hypokalaemia, metabolic alkalosis, hypocalciuria, hypomagnesaemia) [8].
Advanced CKD → accumulation of phosphate, sulphate → high AG metabolic acidosis. Also common to develop hyperK⁺ (↓GFR → ↓K⁺ excretion). Type IV RTA is common in diabetic nephropathy [1].
Likely Exam Questions
-
A patient on losartan with CKD develops K⁺ 6.8 and mild metabolic acidosis with normal AG. What type of RTA? → Type IV RTA (aldosterone antagonism from ARB + CKD).
-
Which treatment for hyperkalaemia does NOT lower serum [K⁺]? → IV calcium gluconate (it stabilises the myocardium but K⁺ remains elevated).
-
SSRI-induced hyponatraemia mechanism? → SIADH.
-
Complication of too-rapid correction of chronic hyponatraemia? → Central pontine myelinolysis (osmotic demyelination syndrome).
-
In DKA, why does K⁺ drop after insulin administration? → Insulin activates Na⁺/K⁺-ATPase → K⁺ shifts into cells. Total body K⁺ already depleted by osmotic diuresis.
Stem (modelled on 2024 SAQ Q11): A 65-year-old male with pH 7.28, pCO₂ 55 mmHg, HCO₃⁻ 22, lactate 4.5 mmol/L.
(a) Primary acid-base disturbance? → Mixed respiratory acidosis (↑pCO₂) AND metabolic acidosis (elevated lactate, base excess −4). HCO₃⁻ appears "normal" but is inappropriately low for the degree of respiratory acidosis (should be higher as compensation) → the lactate elevation confirms a concurrent metabolic acidosis process.
(b) Two investigations within 1 hour? → Blood cultures, CXR (or sputum culture, procalcitonin).
(c) Five management steps? → (1) O₂ supplementation / airway management, (2) IV fluid resuscitation, (3) Empirical IV antibiotics (within 1 hour of sepsis recognition), (4) Blood cultures before antibiotics, (5) Monitor electrolytes / ABG / urine output.
| Trap | Correct Approach |
|---|---|
| Assuming normal K⁺ in DKA means total body K⁺ is normal | Total body K⁺ is DEPLETED; acidosis shifts K⁺ out of cells masking the deficit |
| Using NaHCO₃ freely in metabolic acidosis | Risks: hypoK⁺, ↓ionised Ca²⁺, volume overload, paradoxical cerebral acidosis |
| Correcting chronic hyponatraemia rapidly | Max < 12 mmol/L/day → central pontine myelinolysis |
| Confusing pseudohyponatraemia (normal osm) with dilutional hyponatraemia (low osm) | Always check serum osmolality first |
| Forgetting that IV calcium in hyperK⁺ doesn't lower K⁺ | It only stabilises the myocardium—must also give insulin/dextrose to shift K⁺ |
| Attributing metabolic alkalosis to "too much NaHCO₃" when the real cause is vomiting + volume contraction | Volume contraction maintains alkalosis; saline expansion is the treatment |
| Confusing Bartter's (furosemide-like, hypercalciuria) with Gitelman's (thiazide-like, hypocalciuria) | Gitelman's has hypomagnesaemia and hypocalciuria; Bartter's does not |
High Yield Summary
Acid-Base:
- pH 7.35–7.45; lethal < 7.1 or > 7.7. Acidosis/alkalosis ≠ acidaemia/alkalaemia.
- AG = Na⁺ − Cl⁻ − HCO₃⁻ (normal 8–14). High AG: DKA, lactic acidosis, renal failure, toxins. Normal AG: diarrhoea, RTA.
- Lactic acidosis: Type A (↓O₂ delivery), Type B (no hypoxia—liver disease, metformin). Treat the underlying cause first.
- NaHCO₃ risks: hypoK⁺, ↓Ca²⁺, volume overload, paradoxical cerebral acidosis. Give half dose, aim for pH ~7.1.
- RTA: HypoK⁺ = Type I (distal, stones) or II (proximal, Fanconi). HyperK⁺ = Type IV (aldosterone deficiency/resistance).
Sodium:
- [Na⁺] reflects water balance, not Na⁺ content. Always check osmolality first → then volume status → then urine studies.
- SIADH: euvolaemic hyponatraemia with concentrated urine (Uosm > 100) and UNa > 20. Causes: CNS, respiratory, drugs (SSRIs), hypothyroidism.
- Correction rate: chronic hyponatraemia < 12 mmol/L/day (risk of central pontine myelinolysis).
Potassium:
- K⁺ 3.5–5.0 mmol/L. Shifted by acid-base status. Both hypo and hyperK⁺ → fatal arrhythmia.
- HypoK⁺: ECG shows U waves, flat T, long QT. Treat with oral/IV KCl.
- HyperK⁺: ECG shows peaked T → wide QRS → sine wave. Emergency: IV Ca → insulin/dextrose → NaHCO₃ → HD.
Active Recall - Electrolyte and Acid-Base Disorders
[1] Lecture slides: GC 044. Electrolyte and Acid-Base Disorders.pdf (all pages cited) [2] Senior notes: Adrian Lui Pediatrics Notes.pdf (p310, Acid-base Disorders) [3] Senior notes: Ryan Ho Urogenital.pdf (p13, p34, Disorders of Sodium Balance and Acid-base Balance) [4] Senior notes: Maksim Medicine Notes.pdf (p213, Acid-base disorders compensation table) [5] Past papers: 2021 Fourth Summative Assessment MCQ.pdf (Q55); 2025 Fourth Summative MCQ.pdf (Q11-13); 2024 Fourth Summative SAQ.pdf (Q11) [6] Senior notes: Block A - Two cases of polyuria and polydipsia.pdf (p3, hypokalemia and alkalosis mechanism) [7] Senior notes: Block A - Polyuria and polydipsia_ glucose metabolism; diabetes mellitus; diabetic ketoacidosis.pdf (p12, DKA K+ management) [8] Senior notes: Block A - Nephrotology Teaching Clinic RTD.pdf (p23-27, RTA cases and Bartter syndrome)
Molecular Pathology Seminar 8: Molecular Genetic Testing In Breast Cancer With Case Study
Molecular genetic testing in breast cancer involves analyzing tumor biomarkers such as HER2 amplification, estrogen/progesterone receptor status, and gene expression profiles (e.g., Oncotype DX, MammaPrint) to guide prognosis, predict therapeutic response, and personalize treatment decisions.
GC049 Fever After A Blood Transfusion
A febrile reaction occurring during or shortly after a blood transfusion, most commonly caused by recipient antibodies against donor leukocyte antigens or cytokines accumulated in stored blood products.